{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T16:30:51Z","timestamp":1791477051933,"version":"4.3.4"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"vor","delay-in-days":71,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["24K10776"],"award-info":[{"award-number":["24K10776"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22K07682"],"award-info":[{"award-number":["22K07682"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-026-08449-8","type":"journal-article","created":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T09:37:15Z","timestamp":1781516235000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["First-in-human PET study of [18F]FSW-100 for imaging histone deacetylase 6 in the brain: safety, biodistribution, radiation dosimetry, and brain kinetic analyses"],"prefix":"10.1186","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9545-0922","authenticated-orcid":false,"given":"Tetsuro","family":"Tago","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8161-0916","authenticated-orcid":false,"given":"Muneyuki","family":"Sakata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuto","family":"Kamitaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Kameyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4721-405X","authenticated-orcid":false,"given":"Jun","family":"Toyohara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,15]]},"reference":[{"key":"8449_CR1","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.molonc.2012.07.003","volume":"6","author":"B Barneda-Zahonero","year":"2012","unstructured":"Barneda-Zahonero B, Parra M. Histone deacetylases and cancer. Mol Oncol. 2012;6:579\u201389.","journal-title":"Mol Oncol"},{"key":"8449_CR2","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.3390\/ijms26031274","volume":"26","author":"L Asaad","year":"2025","unstructured":"Asaad L, Pepperrell B, McErlean E, Furlong F. Regulation of HDAC6 Catalytic Activity in Cancer: The Role of Post-Translational Modifications and Protein-Protein Interactions. Int J Mol Sci. 2025;26:1274.","journal-title":"Int J Mol Sci"},{"key":"8449_CR3","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/S0092-8674(03)00939-5","volume":"115","author":"Y Kawaguchi","year":"2003","unstructured":"Kawaguchi Y, Kovacs JJ, McLaurin A, Vance JM, Ito A, Yao TP. The deacetylase HDAC6 regulates aggresome formation and cell viability in response to misfolded protein stress. Cell. 2003;115:727\u201338.","journal-title":"Cell"},{"key":"8449_CR4","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3390\/cells10010012","volume":"10","author":"P LoPresti","year":"2020","unstructured":"LoPresti P. HDAC6 in Diseases of Cognition and of Neurons. Cells. 2020;10:12.","journal-title":"Cells"},{"key":"8449_CR5","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1093\/hmg\/ddt402","volume":"23","author":"C Cook","year":"2014","unstructured":"Cook C, Carlomagno Y, Gendron TF, Dunmore J, Scheffel K, Stetler C, et al. Acetylation of the KXGS motifs in tau is a critical determinant in modulation of tau aggregation and clearance. Hum Mol Genet. 2014;23:104\u201316.","journal-title":"Hum Mol Genet"},{"key":"8449_CR6","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1111\/j.1471-4159.2008.05564.x","volume":"106","author":"H Ding","year":"2008","unstructured":"Ding H, Dolan PJ, Johnson GV. Histone deacetylase 6 interacts with the microtubule-associated protein tau. J Neurochem. 2008;106:2119\u201330.","journal-title":"J Neurochem"},{"key":"8449_CR7","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.bbrc.2012.11.034","volume":"430","author":"S Odagiri","year":"2013","unstructured":"Odagiri S, Tanji K, Mori F, Miki Y, Kakita A, Takahashi H, et al. Brain expression level and activity of HDAC6 protein in neurodegenerative dementia. Biochem Biophys Res Commun. 2013;430:394\u20139.","journal-title":"Biochem Biophys Res Commun"},{"key":"8449_CR8","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1007\/s00259-020-04891-y","volume":"48","author":"M Koole","year":"2021","unstructured":"Koole M, Van Weehaeghe D, Serdons K, Herbots M, Cawthorne C, Celen S, et al. Clinical validation of the novel HDAC6 radiotracer [18F]EKZ-001 in the human brain. Eur J Nucl Med Mol Imaging. 2021;48:596\u2013611.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"8449_CR9","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1002\/acn3.70067","volume":"12","author":"G Vanderlinden","year":"2025","unstructured":"Vanderlinden G, Carron C, Van Weehaeghe D, De Vocht J, Ombelet F, Masrori P, et al. Histone Deacetylase 6 Brain PET in Amyotrophic Lateral Sclerosis-Frontotemporal Spectrum Disorder. Ann Clin Transl Neurol. 2025;12:1350\u20139.","journal-title":"Ann Clin Transl Neurol"},{"key":"8449_CR10","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1021\/acschemneuro.8b00600","volume":"10","author":"AP Kozikowski","year":"2019","unstructured":"Kozikowski AP, Shen S, Pardo M, Tavares MT, Szarics D, Benoy V, et al. Brain Penetrable Histone Deacetylase 6 Inhibitor SW-100 Ameliorates Memory and Learning Impairments in a Mouse Model of Fragile X Syndrome. ACS Chem Neurosci. 2019;10:1679\u201395.","journal-title":"ACS Chem Neurosci"},{"key":"8449_CR11","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1021\/acschemneuro.0c00774","volume":"12","author":"T Tago","year":"2021","unstructured":"Tago T, Toyohara J, Ishii K. Preclinical Evaluation of an 18F-Labeled SW-100 Derivative for PET Imaging of Histone Deacetylase 6 in the Brain. ACS Chem Neurosci. 2021;12:746\u201355.","journal-title":"ACS Chem Neurosci"},{"key":"8449_CR12","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1021\/acscentsci.7b00274","volume":"3","author":"MG Strebl","year":"2017","unstructured":"Strebl MG, Campbell AJ, Zhao WN, Schroeder FA, Riley MM, Chindavong PS, et al. HDAC6 Brain Mapping with [18F]Bavarostat Enabled by a Ru-Mediated Deoxyfluorination. ACS Cent Sci. 2017;3:1006\u201314.","journal-title":"ACS Cent Sci"},{"key":"8449_CR13","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1021\/acschemneuro.0c00074","volume":"11","author":"S Celen","year":"2020","unstructured":"Celen S, Rokka J, Gilbert TM, Koole M, Vermeulen I, Serdons K, et al. Translation of HDAC6 PET Imaging Using [18F]EKZ-001-cGMP Production and Measurement of HDAC6 Target Occupancy in Nonhuman Primates. ACS Chem Neurosci. 2020;11:1093\u2013101.","journal-title":"ACS Chem Neurosci"},{"key":"8449_CR14","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1007\/s00259-024-06666-1","volume":"51","author":"T Tago","year":"2024","unstructured":"Tago T, Sakata M, Kanazawa M, Yamamoto S, Ishii K, Toyohara J. Preclinical validation of a novel brain-penetrant PET ligand for visualization of histone deacetylase 6: a potential imaging target for neurodegenerative diseases. Eur J Nucl Med Mol Imaging. 2024;51:2193\u2013203.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"8449_CR15","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.2967\/jnumed.116.188474","volume":"58","author":"M Sakata","year":"2017","unstructured":"Sakata M, Ishibashi K, Imai M, Wagatsuma K, Ishii K, Zhou X, et al. Initial Evaluation of an Adenosine A2A Receptor Ligand, 11C-Preladenant, in Healthy Human Subjects. J Nucl Med. 2017;58:1464\u201370.","journal-title":"J Nucl Med"},{"key":"8449_CR16","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1007\/s12149-021-01666-9","volume":"35","author":"J Toyohara","year":"2021","unstructured":"Toyohara J, Sakata M, Ishibashi K, Mossel P, Imai M, Wagatsuma K, et al. First clinical assessment of [18F]MC225, a novel fluorine-18 labelled PET tracer for measuring functional P-glycoprotein at the blood-brain barrier. Ann Nucl Med. 2021;35:1240\u201352.","journal-title":"Ann Nucl Med"},{"key":"8449_CR17","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.ejmp.2017.09.124","volume":"42","author":"K Wagatsuma","year":"2017","unstructured":"Wagatsuma K, Miwa K, Sakata M, Oda K, Ono H, Kameyama M, et al. Comparison between new-generation SiPM-based and conventional PMT-based TOF-PET\/CT. Phys Med. 2017;42:203\u201310.","journal-title":"Phys Med"},{"key":"8449_CR18","first-page":"1023","volume":"46","author":"M Stabin","year":"2005","unstructured":"Stabin M, Sparks R, Crowe E. OLINDA\/EXM: the second-generation personal computer software for internal dose assessment in nuclear medicine. J Nucl Med. 2005;46:1023\u20137.","journal-title":"J Nucl Med"},{"key":"8449_CR19","unstructured":"International Commission on Radiological Protection. The 2007 recommendations of the International Commission on Radiological Protection. Ann ICRP. 2007;37(2-4):1-332."},{"key":"8449_CR20","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1007\/s12149-019-01398-x","volume":"33","author":"J Toyohara","year":"2019","unstructured":"Toyohara J, Yamamoto H, Tago T. Searching for diagnostic properties of novel fluorine-18-labeled D-allose. Ann Nucl Med. 2019;33:855\u201365.","journal-title":"Ann Nucl Med"},{"key":"8449_CR21","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1038\/jcbfm.1990.127","volume":"10","author":"J Logan","year":"1990","unstructured":"Logan J, Fowler JS, Volkow ND, Wolf AP, Dewey SL, Schlyer DJ, et al. Graphical analysis of reversible radioligand binding from time-activity measurements applied to [N-11C-methyl]-(-)-cocaine PET studies in human subjects. J Cereb Blood Flow Metab. 1990;10:740\u20137.","journal-title":"J Cereb Blood Flow Metab"},{"key":"8449_CR22","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1097\/00004647-200202000-00012","volume":"22","author":"J Varga","year":"2002","unstructured":"Varga J, Szabo Z. Modified regression model for the Logan plot. J Cereb Blood Flow Metab. 2002;22:240\u20134.","journal-title":"J Cereb Blood Flow Metab"},{"key":"8449_CR23","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1002\/hbm.10123","volume":"19","author":"A Hammers","year":"2003","unstructured":"Hammers A, Allom R, Koepp MJ, Free SL, Myers R, Lemieux L, et al. Three-dimensional maximum probability atlas of the human brain, with particular reference to the temporal lobe. Hum Brain Mapp. 2003;19:224\u201347.","journal-title":"Hum Brain Mapp"},{"key":"8449_CR24","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1096\/fj.07-9574LSF","volume":"22","author":"S Reagan-Shaw","year":"2008","unstructured":"Reagan-Shaw S, Nihal M, Ahmad N. Dose translation from animal to human studies revisited. FASEB J. 2008;22:659\u201361.","journal-title":"FASEB J"},{"key":"8449_CR25","doi-asserted-by":"publisher","first-page":"158","DOI":"10.2967\/jnumed.120.257402","volume":"62","author":"P Zanotti-Fregonara","year":"2021","unstructured":"Zanotti-Fregonara P, Lammertsma AA, Innis RB. 11C Dosimetry Scans Should Be Abandoned. J Nucl Med. 2021;62:158\u20139.","journal-title":"J Nucl Med"},{"key":"8449_CR26","doi-asserted-by":"crossref","unstructured":"International Commission on Radiological Protection. Radiological protection in biomedical research. ICRP Publication 62. Ann ICRP. 1993;22(3):1-28.","DOI":"10.1016\/0146-6453(91)90019-D"},{"key":"8449_CR27","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1007\/s00259-013-2512-x","volume":"40","author":"P Zanotti-Fregonara","year":"2013","unstructured":"Zanotti-Fregonara P, Lammertsma AA, Innis RB. Suggested pathway to assess radiation safety of 18F-labeled PET tracers for first-in-human studies. Eur J Nucl Med Mol Imaging. 2013;40:1781\u20133.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"8449_CR28","unstructured":"United States Food and Drug Administration. Guidance for industry and researchers: the Radioactive Drug Research Committee (RDRC): human research without an investigational new drug application. Silver Spring (MD): United States Food and Drug Administration; 2010."},{"key":"8449_CR29","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s41181-020-00110-z","volume":"5","author":"IM Jackson","year":"2020","unstructured":"Jackson IM, Lee SJ, Sowa AR, Rodnick ME, Bruton L, Clark M, et al. Use of 55 PET radiotracers under approval of a Radioactive Drug Research Committee (RDRC). EJNMMI Radiopharm Chem. 2020;5:24.","journal-title":"EJNMMI Radiopharm Chem"},{"key":"8449_CR30","unstructured":"International Commission on Radiological Protection. 1990 recommendations of the International Commission on Radiological Protection. ICRP Publication 60. Ann ICRP. 1991;21."},{"key":"8449_CR31","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s13550-025-01273-z","volume":"15","author":"SA Norris","year":"2025","unstructured":"Norris SA, Goldman NL, Hamdi M, Moerlein SM, Laforest R, Karimi M, et al. Radiation dosimetry and fasting-dependent hepatobiliary clearance of the VAChT-specific PET radioligand 18F-VAT in humans. EJNMMI Res. 2025;15:83.","journal-title":"EJNMMI Res"},{"key":"8449_CR32","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1038\/ejcn.2013.168","volume":"67","author":"L Marciani","year":"2013","unstructured":"Marciani L, Cox EF, Hoad CL, Totman JJ, Costigan C, Singh G, et al. Effects of various food ingredients on gall bladder emptying. Eur J Clin Nutr. 2013;67:1182\u20137.","journal-title":"Eur J Clin Nutr"},{"key":"8449_CR33","unstructured":"Human Protein Atlas. Brain tissue expression of HDAC6 - Summary [Internet]. Stockholm: Human Protein https:\/\/www.proteinatlas.org\/ENSG00000094631-HDAC6\/brain. Accessed Jul 31, 2025."},{"key":"8449_CR34","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1097\/00004647-199609000-00008","volume":"16","author":"J Logan","year":"1996","unstructured":"Logan J, Fowler JS, Volkow ND, Wang GJ, Ding YS, Alexoff DL. Distribution volume ratios without blood sampling from graphical analysis of PET data. J Cereb Blood Flow Metab. 1996;16:834\u201340.","journal-title":"J Cereb Blood Flow Metab"},{"key":"8449_CR35","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.2967\/jnumed.115.160127","volume":"56","author":"Y Kimura","year":"2015","unstructured":"Kimura Y, Ichise M, Ito H, Shimada H, Ikoma Y, Seki C, et al. PET Quantification of Tau Pathology in Human Brain with 11C-PBB3. J Nucl Med. 2015;56:1359\u201365.","journal-title":"J Nucl Med"},{"key":"8449_CR36","unstructured":"Japanese Society of Nuclear Medicine. Standards for PET drugs used in molecular imaging clinical research. III. Clinical evaluation criteria. Tokyo: Japanese Society of Nuclear Medicine. https:\/\/jsnm.org\/wp_jsnm\/wp-content\/themes\/theme_jsnm\/doc\/3rinsyouhyoukakijun.pdf. Accessed Dec 12, 2025."},{"key":"8449_CR37","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.neubiorev.2019.04.003","volume":"102","author":"MF Ullah","year":"2019","unstructured":"Ullah MF, Ahmad A, Bhat SH, Abu-Duhier FM, Barreto GE, Ashraf GM. Impact of sex differences and gender specificity on behavioral characteristics and pathophysiology of neurodegenerative disorders. Neurosci Biobehav Rev. 2019;102:95\u2013105.","journal-title":"Neurosci Biobehav Rev"},{"key":"8449_CR38","doi-asserted-by":"publisher","first-page":"e180076","DOI":"10.1172\/JCI180076","volume":"134","author":"D Fairweather","year":"2024","unstructured":"Fairweather D, Beetler DJ, McCabe EJ, Lieberman SM. Mechanisms underlying sex differences in autoimmunity. J Clin Invest. 2024;134:e180076.","journal-title":"J Clin Invest"},{"key":"8449_CR39","doi-asserted-by":"publisher","first-page":"1653588","DOI":"10.3389\/fimmu.2025.1653588","volume":"16","author":"Y Liang","year":"2025","unstructured":"Liang Y, Wang Y, Xing J, Li J, Zhang K. The regulatory mechanisms and treatment of HDAC6 in immune dysregulation diseases. Front Immunol. 2025;16:1653588.","journal-title":"Front Immunol"},{"key":"8449_CR40","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1038\/s41589-022-01015-5","volume":"18","author":"S Lechner","year":"2022","unstructured":"Lechner S, Malgapo MIP, Gratz C, Steimbach RR, Baron A, Ruther P, et al. Target deconvolution of HDAC pharmacopoeia reveals MBLAC2 as common off-target. Nat Chem Biol. 2022;18:812\u201320.","journal-title":"Nat Chem Biol"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-08449-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08449-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08449-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T14:59:04Z","timestamp":1787669944000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-08449-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,15]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8449"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-08449-8","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,15]]},"assertion":[{"value":"1 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol (Trial ID: jRCTs031240173) was approved by the Ministry of Health, Labour and Welfare-certified Clinical Research Review Board of the Tokyo Metropolitan Institute for Geriatrics and Gerontology (CRB3180026), and was performed in accordance with the World Medical Association Declaration of Helsinki. Written informed consent was obtained from all individual participants included in the study.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1086"}}